Industry: Chemical & Material
Published Date: 2024-01-16
Pages: 102 Pages
Report ld: 2236191
Request Sample
Customized Report
Beta-Phellandrene (CAS 555-10-2)
The global market for Beta-Phellandrene was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Beta-Phellandrene was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Beta-Phellandrene was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Beta-Phellandrene was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Beta-Phellandrene include Skyrun Industrial Co., Ltd., Manus Aktteva Biopharma LLP, Shanghai Witofly Chemical Co.,Ltd, Flagresso, Angene International Limited, BePharm Ltd., Neostar United Industrial Co., Ltd., Oxchem Corporation and Haihang Industry Co., Ltd., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Beta-Phellandrene, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Beta-Phellandrene by region & country, by Type, and by Application.
The Beta-Phellandrene market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Phellandrene.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Beta-Phellandrene manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Beta-Phellandrene in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Beta-Phellandrene in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Beta-Phellandrene Product Introduction
1.2 Global Beta-Phellandrene Market Size Forecast
1.2.1 Global Beta-Phellandrene Sales Value (2019-2030)
1.2.2 Global Beta-Phellandrene Sales Volume (2019-2030)
1.2.3 Global Beta-Phellandrene Sales Price (2019-2030)
1.3 Beta-Phellandrene Market Trends & Drivers
1.3.1 Beta-Phellandrene Industry Trends
1.3.2 Beta-Phellandrene Market Drivers & Opportunity
1.3.3 Beta-Phellandrene Market Challenges
1.3.4 Beta-Phellandrene Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Beta-Phellandrene Players Revenue Ranking (2023)
2.2 Global Beta-Phellandrene Revenue by Company (2019-2024)
2.3 Global Beta-Phellandrene Players Sales Volume Ranking (2023)
2.4 Global Beta-Phellandrene Sales Volume by Company Players (2019-2024)
2.5 Global Beta-Phellandrene Average Price by Company (2019-2024)
2.6 Key Manufacturers Beta-Phellandrene Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Beta-Phellandrene Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Beta-Phellandrene
2.9 Beta-Phellandrene Market Competitive Analysis
2.9.1 Beta-Phellandrene Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Beta-Phellandrene Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Phellandrene as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity 80%
3.1.2 Purity 95%
3.1.3 Purity 98%
3.1.4 Other
3.2 Global Beta-Phellandrene Sales Value by Type
3.2.1 Global Beta-Phellandrene Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Beta-Phellandrene Sales Value, by Type (2019-2030)
3.2.3 Global Beta-Phellandrene Sales Value, by Type (%) (2019-2030)
3.3 Global Beta-Phellandrene Sales Volume by Type
3.3.1 Global Beta-Phellandrene Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Beta-Phellandrene Sales Volume, by Type (2019-2030)
3.3.3 Global Beta-Phellandrene Sales Volume, by Type (%) (2019-2030)
3.4 Global Beta-Phellandrene Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Fragrances
4.1.2 Insect-Resist & Insecticide
4.1.3 Other
4.2 Global Beta-Phellandrene Sales Value by Application
4.2.1 Global Beta-Phellandrene Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Beta-Phellandrene Sales Value, by Application (2019-2030)
4.2.3 Global Beta-Phellandrene Sales Value, by Application (%) (2019-2030)
4.3 Global Beta-Phellandrene Sales Volume by Application
4.3.1 Global Beta-Phellandrene Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Beta-Phellandrene Sales Volume, by Application (2019-2030)
4.3.3 Global Beta-Phellandrene Sales Volume, by Application (%) (2019-2030)
4.4 Global Beta-Phellandrene Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Beta-Phellandrene Sales Value by Region
5.1.1 Global Beta-Phellandrene Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Beta-Phellandrene Sales Value by Region (2019-2024)
5.1.3 Global Beta-Phellandrene Sales Value by Region (2025-2030)
5.1.4 Global Beta-Phellandrene Sales Value by Region (%), (2019-2030)
5.2 Global Beta-Phellandrene Sales Volume by Region
5.2.1 Global Beta-Phellandrene Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Beta-Phellandrene Sales Volume by Region (2019-2024)
5.2.3 Global Beta-Phellandrene Sales Volume by Region (2025-2030)
5.2.4 Global Beta-Phellandrene Sales Volume by Region (%), (2019-2030)
5.3 Global Beta-Phellandrene Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Beta-Phellandrene Sales Value, 2019-2030
5.4.2 North America Beta-Phellandrene Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Beta-Phellandrene Sales Value, 2019-2030
5.5.2 Europe Beta-Phellandrene Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Beta-Phellandrene Sales Value, 2019-2030
5.6.2 Asia Pacific Beta-Phellandrene Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Beta-Phellandrene Sales Value, 2019-2030
5.7.2 South America Beta-Phellandrene Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Beta-Phellandrene Sales Value, 2019-2030
5.8.2 Middle East & Africa Beta-Phellandrene Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Beta-Phellandrene Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Beta-Phellandrene Sales Value
6.2.1 Key Countries/Regions Beta-Phellandrene Sales Value, 2019-2030
6.2.2 Key Countries/Regions Beta-Phellandrene Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Beta-Phellandrene Sales Value, 2019-2030
6.3.2 United States Beta-Phellandrene Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Beta-Phellandrene Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Beta-Phellandrene Sales Value, 2019-2030
6.4.2 Europe Beta-Phellandrene Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Beta-Phellandrene Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Beta-Phellandrene Sales Value, 2019-2030
6.5.2 China Beta-Phellandrene Sales Value by Type (%), 2023 VS 2030
6.5.3 China Beta-Phellandrene Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Beta-Phellandrene Sales Value, 2019-2030
6.6.2 Japan Beta-Phellandrene Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Beta-Phellandrene Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Beta-Phellandrene Sales Value, 2019-2030
6.7.2 South Korea Beta-Phellandrene Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Beta-Phellandrene Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Beta-Phellandrene Sales Value, 2019-2030
6.8.2 Southeast Asia Beta-Phellandrene Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Beta-Phellandrene Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Beta-Phellandrene Sales Value, 2019-2030
6.9.2 India Beta-Phellandrene Sales Value by Type (%), 2023 VS 2030
6.9.3 India Beta-Phellandrene Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Skyrun Industrial Co., Ltd.
7.1.1 Skyrun Industrial Co., Ltd. Company Information
7.1.2 Skyrun Industrial Co., Ltd. Introduction and Business Overview
7.1.3 Skyrun Industrial Co., Ltd. Beta-Phellandrene Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Skyrun Industrial Co., Ltd. Beta-Phellandrene Product Offerings
7.1.5 Skyrun Industrial Co., Ltd. Recent Development
7.2 Manus Aktteva Biopharma LLP
7.2.1 Manus Aktteva Biopharma LLP Company Information
7.2.2 Manus Aktteva Biopharma LLP Introduction and Business Overview
7.2.3 Manus Aktteva Biopharma LLP Beta-Phellandrene Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Manus Aktteva Biopharma LLP Beta-Phellandrene Product Offerings
7.2.5 Manus Aktteva Biopharma LLP Recent Development
7.3 Shanghai Witofly Chemical Co.,Ltd
7.3.1 Shanghai Witofly Chemical Co.,Ltd Company Information
7.3.2 Shanghai Witofly Chemical Co.,Ltd Introduction and Business Overview
7.3.3 Shanghai Witofly Chemical Co.,Ltd Beta-Phellandrene Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Shanghai Witofly Chemical Co.,Ltd Beta-Phellandrene Product Offerings
7.3.5 Shanghai Witofly Chemical Co.,Ltd Recent Development
7.4 Flagresso
7.4.1 Flagresso Company Information
7.4.2 Flagresso Introduction and Business Overview
7.4.3 Flagresso Beta-Phellandrene Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Flagresso Beta-Phellandrene Product Offerings
7.4.5 Flagresso Recent Development
7.5 Angene International Limited
7.5.1 Angene International Limited Company Information
7.5.2 Angene International Limited Introduction and Business Overview
7.5.3 Angene International Limited Beta-Phellandrene Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Angene International Limited Beta-Phellandrene Product Offerings
7.5.5 Angene International Limited Recent Development
7.6 BePharm Ltd.
7.6.1 BePharm Ltd. Company Information
7.6.2 BePharm Ltd. Introduction and Business Overview
7.6.3 BePharm Ltd. Beta-Phellandrene Sales, Revenue and Gross Margin (2019-2024)
7.6.4 BePharm Ltd. Beta-Phellandrene Product Offerings
7.6.5 BePharm Ltd. Recent Development
7.7 Neostar United Industrial Co., Ltd.
7.7.1 Neostar United Industrial Co., Ltd. Company Information
7.7.2 Neostar United Industrial Co., Ltd. Introduction and Business Overview
7.7.3 Neostar United Industrial Co., Ltd. Beta-Phellandrene Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Neostar United Industrial Co., Ltd. Beta-Phellandrene Product Offerings
7.7.5 Neostar United Industrial Co., Ltd. Recent Development
7.8 Oxchem Corporation
7.8.1 Oxchem Corporation Company Information
7.8.2 Oxchem Corporation Introduction and Business Overview
7.8.3 Oxchem Corporation Beta-Phellandrene Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Oxchem Corporation Beta-Phellandrene Product Offerings
7.8.5 Oxchem Corporation Recent Development
7.9 Haihang Industry Co., Ltd.
7.9.1 Haihang Industry Co., Ltd. Company Information
7.9.2 Haihang Industry Co., Ltd. Introduction and Business Overview
7.9.3 Haihang Industry Co., Ltd. Beta-Phellandrene Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Haihang Industry Co., Ltd. Beta-Phellandrene Product Offerings
7.9.5 Haihang Industry Co., Ltd. Recent Development
8 Industry Chain Analysis
8.1 Beta-Phellandrene Industrial Chain
8.2 Beta-Phellandrene Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Beta-Phellandrene Sales Model
8.5.2 Sales Channel
8.5.3 Beta-Phellandrene Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Beta-Phellandrene was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 133
USD 3950.00
(Single User License)
The global Beta-Phellandrene market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 128
USD 2900.00
(Single User License)
The global Beta-Phellandrene market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 137
USD 4900.00
(Single User License)
The global Beta-Phellandrene market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 76
USD 4250.00
(Single User License)
The global market for Beta-Phellandrene was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 93
USD 3950.00
(Single User License)
The global market for Beta-Phellandrene was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 93
USD 2900.00
(Single User License)
Beta-Phellandrene (CAS 555-10-2)
Published Date: 2024-01-31
Pages: 89
USD 2900.00
(Single User License)
The global market for Beta-Phellandrene was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 133
The global Beta-Phellandrene market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 128
The global Beta-Phellandrene market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 137
The global Beta-Phellandrene market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 76
The global market for Beta-Phellandrene was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 93
The global market for Beta-Phellandrene was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 93
Beta-Phellandrene (CAS 555-10-2)
Published: 2024-01-31
Pages: 89
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now